Matches in SemOpenAlex for { <https://semopenalex.org/work/W2046457953> ?p ?o ?g. }
- W2046457953 endingPage "443" @default.
- W2046457953 startingPage "439" @default.
- W2046457953 abstract "The aim of this study was to compare the analgesic efficacy of premedication with rofecoxib vs intravenous (IV) ketorolac in reducing postoperative pain after arthroscopic knee surgery.This is a prospective, randomized, double-blinded study.This study was set at a university hospital.The subjects include 54 patients with American Society of Anesthesiologists physical statuses I, II, and III undergoing knee arthroscopy.Group 1 received 50 mg oral rofecoxib preoperatively with IV placebo injection, which was administered 20 minutes before the end of the operation. Group 2 received a preoperative placebo and 30 mg IV ketorolac 20 minutes before the end of surgery.The primary outcome measure was the proportion of patients reporting pain in the postoperative anesthesia care unit, 6 hours and 24 hours after discharge. Additional end points included the use of 5:325 mg oxycodone-acetaminophen (O/A) tablets, pain scores, patient's satisfaction survey, and comparison of side effects. Data were analyzed using independent samples t tests for continuous variables or chi2 tests for categorical variables. P < .05 was considered significant.The 2 groups were comparable with regard to patient characteristics, intraoperative medication use, and duration of surgery. There was no difference either in pain scores or O/A use in the postoperative anesthesia care unit. At 24 hours after discharge, significantly more patients in the ketorolac group (91%) reported pain than the rofecoxib group (63%) (P = .02). Sixty-one percent of patients in the ketorolac group used O/A during the first 24 hours vs 38% in the rofecoxib group. The difference, however, was not statistically significant.Preoperative rofecoxib is as effective as ketorolac for the treatment of pain after knee arthroscopy. Higher frequency of pain reporting at 24 hours by patients in ketorolac group is explained by the longer analgesic effect of rofecoxib. Future studies should directly compare gastrointestinal injury of these drugs, as well as cost-effectiveness of rofecoxib vs ketorolac." @default.
- W2046457953 created "2016-06-24" @default.
- W2046457953 creator A5004150127 @default.
- W2046457953 creator A5018408734 @default.
- W2046457953 creator A5024790047 @default.
- W2046457953 creator A5049758270 @default.
- W2046457953 creator A5058043909 @default.
- W2046457953 creator A5085894922 @default.
- W2046457953 date "2005-09-01" @default.
- W2046457953 modified "2023-09-30" @default.
- W2046457953 title "A double-blind prospective comparison of rofecoxib vs ketorolac in reducing postoperative pain after arthroscopic knee surgery" @default.
- W2046457953 cites W1987467897 @default.
- W2046457953 cites W1995790735 @default.
- W2046457953 cites W2011368653 @default.
- W2046457953 cites W2013517733 @default.
- W2046457953 cites W2016029511 @default.
- W2046457953 cites W2021943338 @default.
- W2046457953 cites W2026449570 @default.
- W2046457953 cites W2061342271 @default.
- W2046457953 cites W2079550792 @default.
- W2046457953 cites W2084551508 @default.
- W2046457953 cites W2111912498 @default.
- W2046457953 cites W2117227343 @default.
- W2046457953 cites W2149303604 @default.
- W2046457953 cites W2153800122 @default.
- W2046457953 cites W2412986343 @default.
- W2046457953 cites W4292059951 @default.
- W2046457953 doi "https://doi.org/10.1016/j.jclinane.2004.09.008" @default.
- W2046457953 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16171664" @default.
- W2046457953 hasPublicationYear "2005" @default.
- W2046457953 type Work @default.
- W2046457953 sameAs 2046457953 @default.
- W2046457953 citedByCount "21" @default.
- W2046457953 countsByYear W20464579532012 @default.
- W2046457953 countsByYear W20464579532018 @default.
- W2046457953 countsByYear W20464579532023 @default.
- W2046457953 crossrefType "journal-article" @default.
- W2046457953 hasAuthorship W2046457953A5004150127 @default.
- W2046457953 hasAuthorship W2046457953A5018408734 @default.
- W2046457953 hasAuthorship W2046457953A5024790047 @default.
- W2046457953 hasAuthorship W2046457953A5049758270 @default.
- W2046457953 hasAuthorship W2046457953A5058043909 @default.
- W2046457953 hasAuthorship W2046457953A5085894922 @default.
- W2046457953 hasConcept C126322002 @default.
- W2046457953 hasConcept C141071460 @default.
- W2046457953 hasConcept C142724271 @default.
- W2046457953 hasConcept C168563851 @default.
- W2046457953 hasConcept C170493617 @default.
- W2046457953 hasConcept C181199279 @default.
- W2046457953 hasConcept C185592680 @default.
- W2046457953 hasConcept C188816634 @default.
- W2046457953 hasConcept C204787440 @default.
- W2046457953 hasConcept C27081682 @default.
- W2046457953 hasConcept C2775944032 @default.
- W2046457953 hasConcept C2776029756 @default.
- W2046457953 hasConcept C2776164576 @default.
- W2046457953 hasConcept C2778300832 @default.
- W2046457953 hasConcept C2778446825 @default.
- W2046457953 hasConcept C2778582115 @default.
- W2046457953 hasConcept C2778722691 @default.
- W2046457953 hasConcept C2779689624 @default.
- W2046457953 hasConcept C2780820201 @default.
- W2046457953 hasConcept C2781063702 @default.
- W2046457953 hasConcept C2781072394 @default.
- W2046457953 hasConcept C3020573985 @default.
- W2046457953 hasConcept C42219234 @default.
- W2046457953 hasConcept C55493867 @default.
- W2046457953 hasConcept C71924100 @default.
- W2046457953 hasConceptScore W2046457953C126322002 @default.
- W2046457953 hasConceptScore W2046457953C141071460 @default.
- W2046457953 hasConceptScore W2046457953C142724271 @default.
- W2046457953 hasConceptScore W2046457953C168563851 @default.
- W2046457953 hasConceptScore W2046457953C170493617 @default.
- W2046457953 hasConceptScore W2046457953C181199279 @default.
- W2046457953 hasConceptScore W2046457953C185592680 @default.
- W2046457953 hasConceptScore W2046457953C188816634 @default.
- W2046457953 hasConceptScore W2046457953C204787440 @default.
- W2046457953 hasConceptScore W2046457953C27081682 @default.
- W2046457953 hasConceptScore W2046457953C2775944032 @default.
- W2046457953 hasConceptScore W2046457953C2776029756 @default.
- W2046457953 hasConceptScore W2046457953C2776164576 @default.
- W2046457953 hasConceptScore W2046457953C2778300832 @default.
- W2046457953 hasConceptScore W2046457953C2778446825 @default.
- W2046457953 hasConceptScore W2046457953C2778582115 @default.
- W2046457953 hasConceptScore W2046457953C2778722691 @default.
- W2046457953 hasConceptScore W2046457953C2779689624 @default.
- W2046457953 hasConceptScore W2046457953C2780820201 @default.
- W2046457953 hasConceptScore W2046457953C2781063702 @default.
- W2046457953 hasConceptScore W2046457953C2781072394 @default.
- W2046457953 hasConceptScore W2046457953C3020573985 @default.
- W2046457953 hasConceptScore W2046457953C42219234 @default.
- W2046457953 hasConceptScore W2046457953C55493867 @default.
- W2046457953 hasConceptScore W2046457953C71924100 @default.
- W2046457953 hasIssue "6" @default.
- W2046457953 hasLocation W20464579531 @default.
- W2046457953 hasLocation W20464579532 @default.
- W2046457953 hasOpenAccess W2046457953 @default.
- W2046457953 hasPrimaryLocation W20464579531 @default.